Posttraumatic stress and growth in pulmonary patients recovered from COVID-19.

Publication date: Jan 31, 2025

The COVID-19 pandemic has profoundly affected mental health, with many survivors experiencing psychological challenges, including Post-Traumatic Stress Disorder (PTSD). This study assessed PTSD symptoms and Post-Traumatic Growth (PTG) among 62 individuals recovering from COVID-19 infection, all of whom were under the care of the Department of Pneumonology, Oncology, and Allergology at the Medical University of Lublin. Results revealed that 40. 32% of participants exhibited PTSD symptoms. Key predictors of PTSD severity included cognitive symptoms and post-COVID self-rated health, with cognitive symptoms positively associated and self-rated health negatively associated with PTSD severity. A positive correlation was also found between PTSD severity and PTG, suggesting that while individuals endure significant psychological distress, they may also experience personal growth, such as enhanced resilience and a redefined life perspective. These findings highlight the dual psychological impact of COVID-19 infection, particularly for individuals with preexisting pulmonary conditions. They underscore the importance of holistic, integrated care that addresses both the reduction of PTSD symptoms and the promotion of meaningful psychological growth in COVID-19 survivors.

Open Access PDF

Concepts Keywords
Covid Adult
Enhanced Aged
Oncology COVID-19
Posttraumatic COVID-19 survivors
Ptsd Female
Humans
Male
Mental health
Middle Aged
Post-traumatic growth (PTG)
Posttraumatic Growth, Psychological
Resilience, Psychological
SARS-CoV-2
Stress Disorders, Post-Traumatic
Survivors

Semantics

Type Source Name
disease MESH COVID-19
disease MESH Post-Traumatic Stress Disorder
disease MESH infection
disease MESH psychological distress
disease MESH chronic illness
disease MESH complications
disease MESH depression
disease MESH anxiety
disease MESH dyspnea
disease IDO symptom
disease IDO history
disease MESH Mental Disorders
disease MESH death
disease MESH sexual violence
disease MESH symptom clusters
drug DRUGBANK Coenzyme M
disease IDO intervention
disease MESH Tuberculosis
pathway KEGG Tuberculosis
disease MESH Lung Diseases
disease MESH morbidity
drug DRUGBANK Indoleacetic acid
disease MESH Educational attainment
disease MESH uncertainty
disease MESH reinfection
disease MESH psychological stress
disease MESH inflammation
disease MESH cognitive impairments
disease MESH COPD
disease MESH hypoxemia
disease MESH respiratory diseases
disease MESH oxidative stress
disease IDO process
disease MESH Allergy
disease MESH Post acute COVID 19 syndrome
disease MESH obstructive pulmonary diseases
disease MESH Psychological Trauma
disease MESH interstitial lung disease
disease MESH lung inflammation
disease MESH dementia
pathway REACTOME Reproduction

Original Article

(Visited 4 times, 1 visits today)